Literature DB >> 9474148

Local microwave hyperthermia and intravesical chemotherapy as bladder sparing treatment for select multifocal and unresectable superficial bladder tumors.

R Colombo1, L F Da Pozzo, A Lev, A Salonia, P Rigatti, Z Leib, C Servadio, E Caldarera, M Pavone-Macaluso.   

Abstract

PURPOSE: The role of a combined regimen of local hyperthermia and topical chemotherapy in patients with multifocal and recurrent superficial bladder tumors not curable by transurethral resection was evaluated in a neoadjuvant organ sparing clinical study.
MATERIALS AND METHODS: A total of 19 patients with multifocal, superficial grades 1 to 3 bladder tumors that recurred after intravesical chemoprophylaxis or immunoprophylaxis underwent local combined administration of microwave induced hyperthermia and intravesical chemotherapy as a debulking approach. Due to extensive superficial involvement of the bladder walls complete transurethral resection of all tumors seemed technically unfeasible in all cases and radical cystectomy was considered the treatment of choice. Endovesical hyperthermia at 42.5 to 46C was delivered using the SB-TS 101 system, based on a microwave transurethral applicator that irradiates the bladder filled with a circulating solution of mitomycin C. Patients underwent 8 weekly 1-hour sessions on an outpatient basis without anesthesia. When possible, after treatment patients underwent transurethral resection of residual tumors and all suspicious areas.
RESULTS: After treatment transurethral resection appeared to be feasible and curative in 16 patients (84%). Histological study revealed complete and partial responses in 9 (47%) and 7 (37%) cases, respectively. Due to extensive residual tumors radical cystectomy was performed in 3 patients (16%). At a median 33-month followup 8 superficial transitional tumor recurrences were documented and easily eradicated by transurethral resection or laser therapy in patients in whom the bladder had been saved.
CONCLUSIONS: Microwave induced hyperthermia combined with intravesical mitomycin C seems to be a feasible, safe and elective approach for conservative treatment of multifocal and recurrent superficial bladder tumors when other treatment strategies have failed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9474148

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  7 in total

Review 1.  Adjuvant methods to improve results of local bladder irrigations by chemotherapy for NMIBC.

Authors:  Yuval Freifeld; Yoram Dekel; Avi Stein
Journal:  Curr Urol Rep       Date:  2013-04       Impact factor: 3.092

2.  Effect of local hyperthermia of the bladder on mitomycin C pharmacokinetics during intravesical chemotherapy for the treatment of superficial transitional cell carcinoma.

Authors:  R Paroni; A Salonia; A Lev; L F Da Pozzo; G Cighetti; F Montorsi; P Rigatti; R Colombo
Journal:  Br J Clin Pharmacol       Date:  2001-09       Impact factor: 4.335

3.  Lyso-thermosensitive liposomal doxorubicin for treatment of bladder cancer.

Authors:  Andrew S Mikhail; Ayele H Negussie; William F Pritchard; Dieter Haemmerich; David Woods; Ivane Bakhutashvili; Juan Esparza-Trujillo; Sam J Brancato; John Karanian; Piyush K Agarwal; Bradford J Wood
Journal:  Int J Hyperthermia       Date:  2017-05-10       Impact factor: 3.914

4.  Combined intravesical hyperthermia and mitomycin chemotherapy: a preliminary in vivo study.

Authors:  Lea Rath-Wolfson; Boaz Moskovitz; Yoram Dekel; Valentina Kugel; Rumelia Koren
Journal:  Int J Exp Pathol       Date:  2003-06       Impact factor: 1.925

5.  The effect of thermochemotherapy with mitomycin C on normal bladder urothelium, an experimental study.

Authors:  Murat Uçar; Muammer Altok; Mehmet Umul; Dilek Bayram; İlkay Armağan; Mustafa Güneş; Tahsin Çapkin; Sedat Soyupek
Journal:  Int Urol Nephrol       Date:  2016-01       Impact factor: 2.370

Review 6.  Overview of bladder heating technology: matching capabilities with clinical requirements.

Authors:  Paul R Stauffer; Gerard C van Rhoon
Journal:  Int J Hyperthermia       Date:  2016-03-04       Impact factor: 3.914

7.  The influence of thermo-chemotherapy on bladder tumours: an immunohistochemical analysis.

Authors:  Antoine G van der Heijden; Christina A Hulsbergen-Van de Kaa; J Alfred Witjes
Journal:  World J Urol       Date:  2007-02-14       Impact factor: 4.226

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.